Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CD1d:Ig Fusion Protein Protein

This Recombinant CD1d:Ig Fusion Protein protein is produced in Escherichia coli (E. coli). There are 6 publications available.
Catalog No. ABIN2688828
Shipping to: United States
Contact our Customer Service for availability and price in your country. Contact Info

Quick Overview for CD1d:Ig Fusion Protein Protein (ABIN2688828)

Target

CD1d:Ig Fusion Protein

Protein Type

Recombinant

Origin

Mouse

Source

Escherichia coli (E. coli)

Application

Flow Cytometry (FACS), ELISA
  • Characteristics

    The CD1d:Ig fusion protein consists of the extracellular major histocompatibility complex (MHC) class I-like domains of the mouse CD1d molecule fused with the VH regions of mouse IgG1 (see figure). Like MHC class I molecules, the CD1d noncovalently associates with β2 Microglobulin (β2M). For this reason, BD Pharmingen DimerX consists of recombinant CD1d:Ig and β2M. Recombinant CD1d molecules, like the DimerX fusion protein, are useful for studying Natural Killer T (NKT)-cell function by immunofluorescent staining and flow cytometric analysis of antigen-specific NKT cells. The mouse CD1D1 gene encodes a non-polymorphic cell-surface protein that plays a role in antigen presentation to CD1d-restricted NKT cells. Like the MHC class I molecules, CD1d associates noncovalently with β2M and is capable of binding and presenting lipid antigens. While the natural ligand for CD1d is presently unknown, it is well documented that CD1d can bind and present the glycolipid, α-galactosyl ceramide (α-GalCer*), a glycosphingolipid from the marine sponge. Glycosylphosphatidylinositol (GPI) has also been identified as a major CD1d-associated component. Antigenic glycolipids such as α-GalCer associated with the CD1d molecule are presented and specifically recognized by NKT cells expressing a highly conserved TCR, Vα 14Ja281, paired with diverse β chains such as Vβ 8.2 and Vβ 7. Mouse CD1d:Ig shows differential staining intensities on Vα 14Ja281+ cells, based on the Vβ chain present, with Vβ 8.2+ cells predominantly showing higher intensities than Vβ 7+ cells. The function and lineage marker expression of NKT cells and their interaction with CD1d has been recently reviewed.

    Purification

    The mouse CD1d:Ig fusion protein was expressed together with mouse β2M in the mouse plasmacytoma cell line, J558L (ATCC TIB-6). The CD1d:Ig and β2M polypeptide chains are associated noncovalently as a consequence of their coexpression within J558L cells. The CD1d:Ig fusion protein was purified from tissue culture supernatant by affinity chromatography. The purity of the preparation was confirmed by SDS-PAGE. The CD1d:Ig has been tested by ELISA to verify the fusion protein.
  • Want other Options for this Protein ?

    !
    Discover Our Predefined Custom Proteins and Custom Protein Services!

    Your project requires further customization? Contact us and discover our custom protein solutions

  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Comment

    BD™ DimerX: Recombinant Soluble Dimeric Mouse CD1d:Ig Fusion Protein - Purified

    Restrictions

    For Research Use only
  • Concentration

    0.5 mg/mL

    Buffer

    Aqueous buffered solution containing ≤0.09 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    Store undiluted at 4°C.
  • Schümann, Voyle, Wei, MacDonald: "Cutting edge: influence of the TCR V beta domain on the avidity of CD1d:alpha-galactosylceramide binding by invariant V alpha 14 NKT cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 170, Issue 12, pp. 5815-9, (2003) (PubMed).

    Sidobre, Kronenberg: "CD1 tetramers: a powerful tool for the analysis of glycolipid-reactive T cells." in: Journal of immunological methods, Vol. 268, Issue 1, pp. 107-21, (2002) (PubMed).

    Godfrey, Hammond, Poulton, Smyth, Baxter: "NKT cells: facts, functions and fallacies." in: Immunology today, Vol. 21, Issue 11, pp. 573-83, (2001) (PubMed).

    Hammond, Pellicci, Poulton, Naidenko, Scalzo, Baxter, Godfrey: "CD1d-restricted NKT cells: an interstrain comparison." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 167, Issue 3, pp. 1164-73, (2001) (PubMed).

    Karadimitris, Gadola, Altamirano, Brown, Woolfson, Klenerman, Chen, Koezuka, Roberts, Price, Dusheiko, Milstein, Fersht, Luzzatto, Cerundolo: "Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, Issue 6, pp. 3294-8, (2001) (PubMed).

    Naidenko, Maher, Ernst, Sakai, Modlin, Kronenberg: "Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules." in: The Journal of experimental medicine, Vol. 190, Issue 8, pp. 1069-80, (1999) (PubMed).

  • Target

    CD1d:Ig Fusion Protein

    Sub Type

    Fusionprotein
You are here:
Chat with us!